8-FLUOROISOQUINOLINE-5-CARBONITRILE, 95%, 500mg

(3a'R,4'S,6'R,7'R,7a'S)-4'-((R)-1,4-Dioxaspiro[4.5]decan-2-yl)tetrahydro-4'H-spiro[cyclohexane-1,2'-[1,3]dioxolo[4,5-c]pyran]-6',7'-diol, 98%, 100g

Potassium hexachloroplatinate(IV), min. 99.9%, pa, 500 mg, glass packaging

N-(tert-Butoxycarbonyl)-3-(2-naphthyl)-D-alanine>98.0%(HPLC)(T)5g

1-Phenyl-3-(thiophen-2-yl)-1H-pyrazol-5-amine, 97%, 500mg

6-(Acetylamino)hexanoic acid, 97.0%, 5g

Ethyl 2-(4-chloro-2-fluorophenyl)acetate, 99.0%, 1g

1-(3,4-Dimethoxyphenyl)-2-(2-methoxyphenoxy)-propane-1,3-diol, 95.0%, 5g

3-Fluoro-2-(trifluoromethyl)benzylamine, 1g

Methyl 6-bromo-5-chloronicotinate, 95+%, 1g

(s)-2-Amino-3-(4-bromothiophen-2-yl)propanoic acid, 95%, 500mg

5-Sulfosalicylic Acid Dihydrate>99.0%(HPLC)(T)500g

(S)-2-Amino-2-(4-methoxyphenyl)acetic acid, 97%, 1g